Development and Validation of Disease Biomarkers (R01)
The summary for the Development and Validation of Disease Biomarkers (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development and Validation of Disease Biomarkers (R01): Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Nursing Research (NINR), and the Office of Dietary Supplements (ODS) of the National Institutes of Health, will provide resources to validate candidate biomarkers for well-defined human diseases of the liver, kidney, urological tract, and digestive and hematologic systems, as well as endocrine and metabolic disorders, diabetes and its complications, and obesity, for which there are no or very few biomarkers, or for which standard biomarkers are currently prohibitively invasive or expensive. A biomarker is an indicator of a disease process, and could replace hard clinical end points as a measure of the effect of new therapies. Appropriate studies will validate candidate biomarkers in well-defined patient populations, provide new technologies to monitor biomarkers or establish reliable assays for validated markers. Progress in this area has the potential to advance translational research related to efficacy of treatments and bio-behavioral interventions. This FOA is not appropriate for biomarker discovery projects. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Developmental/Exploratory Research (R21) applications within the scientific scope of the FOA can be submitted in response to the NIH Parent R21 PA http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: | Development and Validation of Disease Biomarkers (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Food and Nutrition Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-09-204 |
Type of Funding: | Grant |
CFDA Numbers: | 93.273 |
CFDA Descriptions: | Alcohol Research Programs |
Current Application Deadline: | Sep 07, 2012 |
Original Application Deadline: | Sep 07, 2012 |
Posted Date: | Jun 03, 2009 |
Creation Date: | Jun 04, 2009 |
Archive Date: | Oct 08, 2012 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...
- • Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...
- • Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...
- • Mechanisms of Alcoholic Pancreatitis
- • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
- • Mechanisms of Alcohol-Induced Tissue Injury
- More Grants from the National Institutes of Health
- • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
- • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...